Following Earlier memories For its smoking cessation drug Chantix, Pfizer (PTFE) The recall has been expanded to include four other batches of the drug because it may also contain N-nitrosovarenicline-a substance that may cause cancer-above the acceptable daily limit set by the Food and Drug Administration intake.
N-nitrosovarenicline is commonly found in water and food, including pickled and roasted meats, dairy products, and vegetables. N-nitrosovarenicline is a possible carcinogen, and long-term intake may increase the risk of cancer.
However, Pfizer said that people taking Chantix have no direct risk because the health benefits of quitting smoking outweigh the cancer risk of this impurity.
The recalled Chantix drug can help people quit smoking and is intended for short-term use.
The recalled batches were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from June 2019 to June 2021. The drug is provided to consumers in the form of 0.5 mg/1 mg tablets.
A complete list of all recalled Chantix products and labels can be viewed here.
Consumers taking Chantix should consult their healthcare provider or pharmacy to determine if they have an affected product batch.
If consumers have a recalled drug, they should call Stericycle Inc. at 1-888-276-6166 from 8 am to 5 pm Eastern time Monday to Friday for instructions on how to return the product and obtain reimbursement medicine.
To report adverse drug reactions or product complaints, please call 1-800-438-1985, option 1, and contact the Pfizer Drug Safety Department 24 hours a day, 7 days a week.
Pfizer said it has not received any reports of adverse events related to the recalled drugs.
As of 10:43 AM Eastern Time on Tuesday, Pfizer’s stock price was $50.36, up $1.45 or 2.96%.
Photo: AFP/Don Emmert
